Global Computed Tomography (CT) Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Type;
Low Slice, Medium Slice, and High SliceBy Application;
Oncology, Neurology, Cardiovascular, Diagnostics, and OthersBy End User;
Hospitals, Clinics, Diagnostic Services, and OthersBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)Computed Tomography (CT) Market Overview
Computed Tomography (CT) Market (USD Million)
Computed Tomography (CT) Market was valued at USD 7,703.76 million in the year 2024. The size of this market is expected to increase to USD 11,583.61 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.0%.
Global Computed Tomography (CT) Market Growth, Share, Size, Trends and Forecast
*Market size in USD million
CAGR 6.0 %
Study Period | 2025 - 2031 |
---|---|
Base Year | 2024 |
CAGR (%) | 6.0 % |
Market Size (2024) | USD 7,703.76 Million |
Market Size (2031) | USD 11,583.61 Million |
Market Concentration | Medium |
Report Pages | 374 |
Major Players
- Fujifilm
- GE Healthcare
- Hitachi Healthcare Systems
- NeuroLogica Corporation
- Neusoft Medical Systems Co. Ltd
- Phillips
- Samsung
- Shenzhen Anke High-Tech Co
- Siemens
- Toshiba Medical Systems
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Global Computed Tomography (CT) Market
Fragmented - Highly competitive market without dominant players
The Computed Tomography (CT) Market is witnessing robust growth, primarily driven by the rising demand for precise diagnostic imaging. CT technology, known for producing detailed cross-sectional images, plays a crucial role in modern medical diagnostics. Currently, over 65% of advanced healthcare institutions utilize CT systems for critical diagnostics, underlining their essential role in accurate disease detection and treatment planning.
Impact of Chronic Disease Prevalence
The surge in chronic disease cases, including cardiovascular disorders and cancers, is a significant factor fueling the demand for CT imaging. Approximately 70% of cancer diagnoses utilize CT scans at some stage, emphasizing the critical role of this technology in oncology. Additionally, close to 40% of heart disease assessments involve CT angiography, highlighting its pivotal importance in cardiology.
Technological Advancements Driving Market Growth
Technological innovation is reshaping the CT market, with significant advancements in imaging speed, reduced radiation exposure, and enhanced image clarity. Over 55% of newly installed CT systems now incorporate AI-powered image enhancement and automated workflow solutions, improving both diagnostic precision and operational efficiency.
Rising Adoption in Emergency Medical Care
CT technology has become indispensable in emergency medicine, where rapid, high-precision imaging is essential for critical decision-making. Nearly 30% of emergency room diagnoses rely on CT scans, particularly for trauma, stroke, and internal bleeding assessments, reinforcing its vital role in acute care settings.
Market Outlook and Growth Potential
With continuous innovation and increasing healthcare investments, the CT market is positioned for sustained growth. More than 60% of hospitals are expected to upgrade to next-generation CT systems in the coming years, driven by the demand for faster diagnostics, improved image quality, and better patient outcomes.
Computed Tomography (CT) Market Recent Developments
-
In 2023, Siemens Healthineers unveiled a high-resolution CT scanner designed to improve diagnostic accuracy.
-
In 2022, GE Healthcare completed a strategic acquisition to enhance its advanced CT imaging portfolio.
Computed Tomography (CT) Market Segment Analysis
In this report, the Computed Tomography (CT) Market has been segmented by Type, Application, End User, and Geography.
Computed Tomography (CT) Market, Segmentation by Type
The Computed Tomography (CT) Market has been segmented by Type into Low Slice, Medium Slice, and High Slice.
Low Slice
Low slice CT scanners make up approximately 25% of the computed tomography market. These systems, often with up to 16 slices, are ideal for basic diagnostic applications and are frequently deployed in small clinics and rural healthcare settings. Their cost-efficiency and operational simplicity make them popular in low-resource environments.
Medium Slice
Medium slice CT systems, covering 32 to 64 slices, dominate with about 40% of the market share. They are commonly used for routine imaging, including cardiac, abdominal, and trauma assessments, offering a solid compromise between speed, accuracy, and affordability. Their versatility supports broad clinical usage across healthcare facilities.
High Slice
High slice CT systems, with 128 slices or more, hold a significant 35% of the global share. These systems are essential in advanced clinical environments where high-resolution imaging is required for complex conditions like oncology, neurology, and vascular diseases. The increasing need for precision diagnostics is boosting demand in this segment.
Computed Tomography (CT) Market, Segmentation by Application
The Computed Tomography (CT) Market has been segmented by Application into Oncology, Neurology, Cardiovascular, Diagnostics, and Others.
Oncology
Oncology represents approximately 30% of the computed tomography market. CT scans are extensively used in cancer diagnosis, tumor staging, and treatment monitoring, making them essential in oncology workflows. With cancer rates rising globally, demand for high-resolution imaging continues to surge.
Neurology
Neurology accounts for about 20% of the CT market. CT imaging is instrumental in detecting brain injuries, strokes, and neurological anomalies. The increasing incidence of neurodegenerative disorders and the need for rapid diagnosis are driving adoption in this segment.
Cardiovascular
Cardiovascular applications comprise nearly 18% of market share. Techniques like CT angiography enable non-invasive imaging of the heart and blood vessels. The escalating burden of cardiovascular diseases and focus on early detection are fueling growth.
Diagnostics
General diagnostics make up roughly 25% of the CT market. From abdominal and thoracic scans to emergency assessments, CT technology is widely used for its speed, accuracy, and broad clinical utility, especially in acute care settings.
Others
The others segment contributes about 7%, covering orthopedic, dental, and interventional radiology procedures. Specialized CT applications are gaining popularity due to technological advancements and growing demand for customized imaging solutions.
Computed Tomography (CT) Market, Segmentation by End User
The Computed Tomography (CT) Market has been segmented by End User into Hospitals, Clinics, Diagnostic Services and Others.
Hospitals
Hospitals represent the largest share of the computed tomography market at around 50%. Their dominance is driven by access to advanced diagnostic infrastructure, the need for emergency imaging, and integration into multi-specialty care workflows. High patient volumes and 24-hour services contribute to consistent demand.
Clinics
Clinics contribute about 20% of the market. They typically perform routine CT scans, offering quick diagnostics in a more accessible and cost-effective setting. The rise in outpatient care and ambulatory services is fueling CT system adoption in clinical environments.
Diagnostic Services
Diagnostic imaging centers hold an estimated 25% market share. These standalone facilities specialize in CT imaging, often handling high patient throughput and benefiting from referral-based workflows. Their focus on speed and efficiency makes them essential for timely diagnostic care.
Others
The others category accounts for roughly 5%, including research organizations, mobile CT units, and veterinary clinics. These emerging applications reflect the increasing versatility of CT technology beyond traditional healthcare settings.
Computed Tomography (CT) Market, Segmentation by Geography
In this report, the Computed Tomography (CT) Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.
Regions and Countries Analyzed in this Report
Computed Tomography (CT) Market Share (%), by Geographical Region
North America
North America dominates the computed tomography market with an estimated 35% share. The region’s leadership stems from widespread use of advanced diagnostic imaging, robust healthcare infrastructure, and continuous technological innovation. The U.S. remains a major hub for CT system utilization across hospitals and diagnostic centers.
Europe
Europe contributes nearly 25% of the CT market. Nations such as Germany, France, and the United Kingdom are leading adopters, thanks to extensive government healthcare funding, focus on early disease detection, and consistent investments in medical imaging research.
Asia Pacific
Asia Pacific accounts for approximately 22% of the CT market and is poised for the fastest growth. The surge in healthcare spending, coupled with a rising aging population and expansion of private healthcare, is fueling demand for CT systems across India, China, and Japan.
Middle East & Africa
Middle East & Africa make up around 10% of the CT market. While adoption varies across regions, countries in the GCC are investing in healthcare infrastructure, boosting diagnostic imaging capacity. However, some areas continue to face resource and affordability challenges.
Latin America
Latin America holds nearly 8% of the market. Growth is driven by improving healthcare access, rising incidence of chronic diseases, and efforts to upgrade diagnostic capabilities in countries like Brazil and Mexico.
Computed Tomography (CT) Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Computed Tomography (CT) Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Comprehensive Market Impact Matrix
This matrix outlines how core market forces—Drivers, Restraints, and Opportunities—affect key business dimensions including Growth, Competition, Customer Behavior, Regulation, and Innovation.
Market Forces ↓ / Impact Areas → | Market Growth Rate | Competitive Landscape | Customer Behavior | Regulatory Influence | Innovation Potential |
---|---|---|---|---|---|
Drivers | High impact (e.g., tech adoption, rising demand) | Encourages new entrants and fosters expansion | Increases usage and enhances demand elasticity | Often aligns with progressive policy trends | Fuels R&D initiatives and product development |
Restraints | Slows growth (e.g., high costs, supply chain issues) | Raises entry barriers and may drive market consolidation | Deters consumption due to friction or low awareness | Introduces compliance hurdles and regulatory risks | Limits innovation appetite and risk tolerance |
Opportunities | Unlocks new segments or untapped geographies | Creates white space for innovation and M&A | Opens new use cases and shifts consumer preferences | Policy shifts may offer strategic advantages | Sparks disruptive innovation and strategic alliances |
Drivers, Restraints and Opportunity Analysis
Drivers:
- Increasing Incidences of Cancer & Chronic diseases
- Increase in the Global Population
-
Growing Public Awareness for Healthcare - The rise in public awareness regarding health and early disease detection is a key driver accelerating the growth of the Computed Tomography (CT) market. With increasing educational initiatives, media coverage, and access to health information, individuals are becoming more proactive in seeking timely diagnostic evaluations. This trend is fostering a surge in demand for advanced imaging technologies like CT, which offer rapid, non-invasive, and accurate assessments of internal structures for a wide range of medical conditions.
In both developed and developing regions, awareness campaigns emphasizing the importance of preventive healthcare and routine screening are contributing to the rising number of diagnostic procedures. CT imaging is widely recognized for its role in detecting conditions such as cancer, cardiovascular diseases, and neurological disorders at early stages. The growing public understanding of these benefits is directly influencing healthcare-seeking behavior, thereby supporting broader adoption of CT systems and contributing to improved patient outcomes through timely diagnosis and intervention.
Restraints:
- Reimbursement Issues Healthcare
- Expensive Procedures & Equipment
-
Limited Access to Advanced Healthcare Infrastructure - Limited access to advanced healthcare infrastructure remains a significant restraint on the Computed Tomography (CT) market, especially in low- and middle-income countries. Many regions face challenges such as inadequate funding, outdated equipment, and insufficient medical facilities, which hinder the installation and utilization of high-end CT systems. These limitations restrict patient access to timely and accurate diagnostic imaging, ultimately impacting the quality of care and early disease detection efforts.
The scarcity of qualified radiology professionals, lack of technical support, and unreliable electricity or digital connectivity further exacerbate the problem. Without a robust infrastructure in place, even when CT machines are available, their operation and maintenance become difficult. This disparity in access creates a pronounced healthcare gap between urban and rural areas, limiting the global market potential of CT systems despite rising awareness and diagnostic demand. Addressing this barrier requires strategic investments in infrastructure development, public-private partnerships, and healthcare workforce training to ensure more equitable and effective deployment of CT technologies.
Opportunities:
- Expansion of Healthcare Tourism
- Strategic Collaborations and Partnerships
-
Focus on Patient-Centric Healthcare Solutions - The increasing focus on patient-centric healthcare solutions is opening substantial opportunities for growth in the Computed Tomography (CT) market. As healthcare systems transition toward models that prioritize individual needs, comfort, and outcomes, there is a growing demand for diagnostic technologies that align with these values. CT systems are being redesigned to enhance patient experience through reduced scan times, lower radiation doses, and greater imaging precision, which contribute to safer and more personalized diagnostic care.
Modern CT technologies are evolving to support tailored diagnostic pathways, especially for patients with chronic or complex conditions who require frequent imaging. These systems now integrate with electronic health records and decision support tools, enabling clinicians to deliver data-driven and patient-specific diagnoses. This integration supports the goals of value-based healthcare by facilitating earlier intervention, minimizing unnecessary procedures, and improving long-term clinical outcomes.
Moreover, patient-centric CT innovations are expanding access for populations with special needs, including pediatric, geriatric, and critically ill patients. Advanced scanners with adaptive protocols and motion correction algorithms are designed to accommodate patients who may have difficulty remaining still, enhancing image clarity while ensuring comfort and safety. These improvements not only increase diagnostic accuracy but also build greater trust and satisfaction among patients.
As global healthcare providers strive to enhance the overall patient journey, investment in human-centered imaging solutions is expected to accelerate. Manufacturers who prioritize innovations that reflect empathy, personalization, and efficiency will likely gain a competitive edge. This emphasis on patient-focused design in CT technology supports broader trends in healthcare modernization and will be central to the market’s sustained expansion.
Computed Tomography (CT) Market Competitive Landscape Analysis
Key players in Computed Tomography (CT) Market include:
- Fujifilm
- GE Healthcare
- Hitachi Healthcare Systems
- NeuroLogica Corporation
- Neusoft Medical Systems Co. Ltd
- Phillips
- Samsung
- Shenzhen Anke High-Tech Co
- Siemens
- Toshiba Medical Systems
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Market Share Analysis
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Computed Tomography (CT) Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Increasing Incidences of Cancer & Chronic diseases
- Increase in the Global Population
- Growing Public Awareness for Healthcare
- Restraints
- Reimbursement Issues Healthcare
- Expensive Procedures & Equipment
- Limited Access to Advanced Healthcare Infrastructure
- Opportunities
- Expansion of Healthcare Tourism
- Strategic Collaborations and Partnerships
- Focus on Patient-Centric Healthcare Solutions
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Computed Tomography (CT) Market, By Type, 2021 - 2031 (USD Million)
- Low Slice
- Medium Slice
- High Slice
- Computed Tomography (CT) Market, By Application, 2021 - 2031 (USD Million)
- Oncology
- Neurology
- Cardiovascular
- Diagnostics
- Others
- Computed Tomography (CT) Market, By End User, 2021 - 2031 (USD Million)
- Hospitals
- Clinics
- Diagnostic Services
- Others
- Computed Tomography (CT) Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Computed Tomography (CT) Market, By Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Fujifilm
- GE Healthcare
- Hitachi Healthcare Systems
- NeuroLogica Corporation
- Neusoft Medical Systems Co. Ltd
- Phillips
- Samsung
- Shenzhen Anke High-Tech Co
- Siemens
- Toshiba Medical Systems
- Company Profiles
- Analyst Views
- Future Outlook of the Market